Abstract
Human respiration is accompanied with abundant physiological and pathological information, such as the change in ammonia (NH3) content, which is related to chronic kidney disease (CKD); hence, monitoring the breathing behavior helps in health assessment and illness prediction. In this work, a wearable respiration sensor based on CeO2@polyaniline (CeO2@PANI) nanocomposites that underwent a hydrogen plasma treatment is developed. The results unambiguously show that the response of the corresponding nanocomposites is significantly enhanced from 165 to 670% to 100 ppm NH3 compared to the counterpart that did not undergo hydrogen plasma treatment and even reaches 24% to 50 ppb NH3, suggesting its fascinating capability of detecting the trace level of NH3 in human breathing. The superior response for NH3 is ascribed to the stable oxygen vacancies produced by the hydrogen plasma treatment. Furthermore, the clinical tests for patients with uremia suggest that the as-designed sensor has potential applications in clinical monitoring for CKD. Herein, this work offers a new strategy to obtain respiration sensors with high performance and provides a feasible approach for health evaluation and disease monitoring of patients with CKD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.